GlucaGen

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1980-2018
01219802018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
OBJECTIVE Treatment of severe hypoglycemia outside of the hospital setting is limited to glucagon formulations requiring… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
2016
2016
BACKGROUND There is currently no stable liquid form of glucagon commercially available. The aim of this study is to assess the… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
AIM To investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of LY2189265 (LY), a novel, long-acting… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2010
2010
BACKGROUND For automated prevention of hypoglycemia, there is a need for glucagon (or an analog) to be sufficiently stable so… (More)
Is this relevant?
2010
2010
To the Editor: Among the possible cellular therapies to replace insulin secretion in diabetes, bone marrow-derived stem cells… (More)
  • table 1
  • table 2
Is this relevant?
2008
2008
Purpose: Peristalsis of the small bowel leads to considerable movement artifacts in MR-examinations, which hamper diagnostic… (More)
  • figure 1
  • figure 2
Is this relevant?
2006
2006
INTRODUCTION Few reports have documented allergic hypersensitivity reactions after barium gastrointestinal studies. Of these, the… (More)
  • figure 1
  • figure 1
Is this relevant?
1980
1980
1. The effect of oleate on the subcellular distribution of ATP, 2-oxoglutarate, glutamate, citrate, malate and… (More)
Is this relevant?